Transcriptomics

Dataset Information

0

Expression data from mice bladder with MB49-induced cancer treated with Lon protease


ABSTRACT: MYC has been named the quintessential oncogene and is deregulated in the majority of human cancers. Still, finding c-MYC inhibitors for therapeutic use has been problematic and MYC itself has long been viewed as “undruggable”. Here we present a novel strategy for achieving c-MYC inhibition, involving specific bacterial effector molecules. We made the surprising observation that uropathogenic E. coli activate c-MYC degradation and attenuate MYC expression in host cells and tissues. We further identified effector molecules responsible for this effect. The bacterial Lon protease is shown to rapidly degrade c-MYC and therapeutic efficacy is demonstrated in bladder and colon cancer models. Long-term protection, defined by delayed tumor progression, increased survival and low toxicity further supports the therapeutic potential of Lon. These results suggest that bacteria have evolved strategies to control c-MYC tissue levels in the host, which can be exploited to target c-MYC therapeutically in different cancers.

ORGANISM(S): Mus musculus

PROVIDER: GSE162251 | GEO | 2021/02/10

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-02-10 | GSE162252 | GEO
2021-02-10 | GSE162250 | GEO
2020-06-30 | GSE137273 | GEO
2016-01-06 | GSE73023 | GEO
2016-01-06 | E-GEOD-73023 | biostudies-arrayexpress
2015-12-31 | E-GEOD-65437 | biostudies-arrayexpress
2020-06-14 | GSE152426 | GEO
2007-11-01 | GSE6609 | GEO
2012-03-25 | E-MTAB-1000 | biostudies-arrayexpress
2023-10-25 | PXD036514 | Pride